SFV HEALTHCARERecent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
MannKind Corp. Chief Executive Hakan Edstrom announced his resignation from the Valencia biopharmaceutical company Friday.
The Food and Drug Administration on Wednesday accepted paperwork for approval of a biosimilar version of Amgen Inc.’s Neulasta, a drug that produces white blood cells to fight infection in cancer patients.
Shareholders of IPC Healthcare Inc. formally approved the pending $1.6 billion acquisition by Team Health Holdings Inc., the company announced Tuesday.
Apollo Medical Holdings Inc. turned to a loss during the third quarter, the company announced Tuesday.
IPC Healthcare Inc. announced today that it has acquired Amity Health LLC in Wichita, Kan.
MannKind Corp. shares had a double-digit loss after the company released its quarterly earnings.
Apollo Medical Holdings Inc. announced Tuesday a collaboration with data analytics firm Helynx Inc. in Pasadena to identify high-risk patients and improve their health care.
According to media reports, Amgen Inc. is in the hunt to acquire a biotech company worth about $10 billion.
Anthem Blue Cross in Thousand Oaks has announced a strategic relationship with Castlight Health Inc., an enterprise health care management company based in San Francisco.
LTC Properties Inc. reported an increase in its third-quarter earnings and exceeded Wall Street expectations on funds from operations.
Health Net Inc. announced third-quarter earnings that matched Wall Street expectations Monday, even as the company plans to finalize its planned merger early next year.
Visual prosthetics manufacturer Second Sight Medical Products Inc. reported its third-quarter financial results on Thursday.
Amgen Inc. beat Wall Street expectations with its third-quarter financial results on Wednesday.
MannKind Corp. announced Monday that 9 million shares of its common stock were returned by Bank of America according to a stock lending agreement from 2010.
MannKind Corp. announced Friday that its stock is approved for listing on the Tel Aviv Stock Exchange.